Biogen (BIIB) Slipped on Lower-Than-Expected Revenue Growth

ClearBridge Investments outperformed the Russell 1000 Value Index in Q1 2024. The ClearBridge Value Equity Strategy showed gains in most sectors, with top contributors in financial and utilities. Biogen Inc. was highlighted in the investor letter, with a one-month return of -2.